Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Operating activities:
Net loss	$ (2,105,174)	$ (999,380)
Adjustments to reconcile net loss from operations to net cash used in operating activities:
Depreciation and Amortization	3,462	682
Deferred consulting fees	187,377	148,924
Amortization of Stock options	557,167	277,205
Common stock issued for services	120,000	0
Amortization of financing fees	14,000	0
Amortization of detachable warrants	0	17,696
Beneficial conversion feature	0	148,183
Amortization of discounts	51,116	0
Changes in operating assets and liabilities:
Inventory	(252,933)	0
Accounts receivable	9,573	0
Prepaid expenses and other assets	308,133	355
Accounts payable and accrued expenses	(273,692)	113,503
Accounts payable and accrued expenses - related parties	0	6,617
Deferred sales	0	4,966
Net cash used in operating activities	(1,380,971)	(281,249)
Investing activities:
Additions to fixed assets	(23,442)	(13,750)
Intellectual property	0	(7,440)
Net cash used in investing activities	(23,442)	(21,190)
Financing activities:
Loan proceeds	250,000	315,000
Proceeds from warrant exercise	1,521,324	0
Financing charges paid	(122,578)	0
Net cash provided by investing activities	1,648,746	315,000
Net increase in cash and cash equivalents	244,333	12,561
Cash and cash equivalents, beginning of period	62,050	147,905
Cash and cash equivalents, end of period	306,383	160,466
Supplemental Cash Flow Information:
Common stock issued for convertible notes payable and accrued interest	138,001	511,767
Common stock issued for financing fees	$ 300,118	$ 0